JaLCDOI 10.18926/AMO/54001
FullText URL 70_1_31.pdf
Author Hanada, Takae| Kanamitsu, Kiichiro| Chayama, Kosuke| Miyamura, Takako| Kanazawa, Yui| Muraoka, Michiko| Washio, Kana| Imada, Masahide| Kageyama, Misao| Takeuchi, Akihito| Tamai, Kei| Oda, Megumi| Shimada, Akira|
Abstract The treatment of patients with congenital leukemia is difficult and often results in a poor prognosis. We present here the case of a female child with congenital acute myeloid leukemia (AML) with t(8 ; 16) (p11 ; p13) who received chemotherapy and survived for more than 10 years without relapse. A novel MOZ-CBP chimera was found in her diagnostic sample. Although adult AML patients with MOZ-CBP have mainly been reported as having therapy-related AML and showed poor prognoses, the present case supports the idea that AML with MOZ-CBP in the pediatric population might show better prognoses.
Keywords congenital leukemia AML t(8 ; 16)(p11 ; p13) MOZ-CBP
Amo Type Original Article
Published Date 2016-02
Publication Title Acta Medica Okayama
Volume volume70
Issue issue1
Publisher Okayama University Medical School
Start Page 31
End Page 35
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language 英語
Copyright Holders CopyrightⒸ 2016 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 26899607
Web of Science KeyUT 000371288700004